Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...
Weight loss drugs quickly became the go-to tactic for celebrities like Fat Joe, Kathy Bates, Macy Gray, Kelly Clarkson, Rebel ...
45m
Scripps News on MSNHims and Hers likely to stop selling cheaper versions of GLP-1 medicationsThe FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
MarketWatch on MSN1h
Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much ...
Hosted on MSN14m
Update on Pope Francis, latest on Listeria OutbreakBreaking down the latest on the listeria outbreak throughout the country; Update on condition of Pope Francis; Ozempic ...
Ozempic and its contemporaries are the new craze. But would you believe it when we say that these weight-loss drugs would be ...
Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of ...
20m
Hosted on MSNThyroid Cancer Is Overdiagnosed in the U.S.—Could Ozempic Be Making the Problem Worse?Fact checked by Nick Blackmer Weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year ...
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results